Wiltrom Business Summary

Wiltrom Co., Ltd. (6767.TWO) is a specialized medical device manufacturer that generates revenue through the development, production, and global sale of Class II and III implantable spinal surgery solutions. The company's primary business segments are categorized into spinal fusion systems (including pedicle screws and interbody cages), vertebral body augmentation systems for compression fractures, and synthetic bone graft substitutes. Wiltrom distinguishes itself in the market through its focus on minimally invasive surgery (MIS) instruments and proprietary biodegradable materials, such as its flagship Tripod-Fix and Bicera bone substitutes. Within the competitive landscape, Wiltrom operates as a high-growth niche innovator, competing directly with regional players like United Orthopedic Corporation, BAUI Biotech, and Intai Technology, while positioning its cost-effective, clinically-integrated designs against global giants such as Stryker and Medtronic. Founded in 2009 as a high-tech spin-off from Taiwan’s Industrial Technology Research Institute (ITRI), the leadership team is anchored by a core group of researchers with deep technical pedigrees. Chairman Huang-Chien Liang, a Ph.D. in Chemical Engineering from National Tsing Hua University, previously served as a Principal Investigator at ITRI’s Institute of Biomedical Sciences. He is supported by CEO (General Manager) Chia-Mao Lee, who brings extensive commercial expertise from his former roles as CEO and CFO of Pacific Hospital Supply Co., Ltd. The executive suite is further strengthened by COO Yi-Chun Su and R&D Director Hung-Yin Tai, both ITRI alumni with doctoral backgrounds in molecular biology and chemical engineering, respectively. This technical foundation is backed by a board that reflects the company's origins in state-sponsored research and its transition to a publicly traded entity on the Taipei Exchange.